A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2007
11/21/2007	EP0871463B2 Regulation of eating behavior
11/21/2007	EP0842196B1 Cell adhesion inhibitors
11/21/2007	EP0529031B9 Improved inhibitors of thrombin
11/21/2007	EP0522091B9 Use of a mbp peptide for the preparation of a medicament for the treatment of multiple sclerosis
11/21/2007	CN101076586A Detection, isolation and uses of renalase (monoamine oxidase C)
11/21/2007	CN101076353A Releasable polymer conjugate based on aliphatic biodegradable joint
11/21/2007	CN101076350A Compositions for hcv treatment
11/21/2007	CN101076349A Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues
11/21/2007	CN101076348A Compositions and methods for inducing melanogenesis in a subject
11/21/2007	CN101076347A Devices and methods for integrated continuous manufacturing of biological molecules
11/21/2007	CN101076345A Medicine for preventing and curing human genital system disorder and method for manufacturing the same
11/21/2007	CN101076314A Methods of inducing melanogenesis in a subject
11/21/2007	CN101074437A Reptilase I-type enzyme products and its production
11/21/2007	CN101074268A Tranduced peptide-huamn erythrogenin fusion protein and its medicinal composition
11/21/2007	CN101074267A Transduced peptide-humanized granular leukocyte macrophage colony stimulating factor fusion protein and its medicinal composition
11/21/2007	CN101074266A Transduced peptide-humanized granular leukocyte colony stimulating factor fusion protein and its medicinal composition
11/21/2007	CN101073667A Enhancer for antibody to lymphocytic tumors
11/21/2007	CN101073666A Method for producing high-purity kallidin proenzyme raw-material medicine
11/21/2007	CN101073665A Use of lymphotoxin in treatment of medicine for increasing chemoradiotherapeutic sensitivity
11/21/2007	CN101073664A Uso of W-peptide in treatment of tumor
11/21/2007	CN100350050C Pseudomycin production by pseudomonas syringae
11/21/2007	CN100349915C Amido glycoside of sea pearl oyster, prepartion method, and usage
11/21/2007	CN100349632C Microprojection array having beneficial agent contg coating
11/21/2007	CN100349620C Method of creating biological and biosynthetic material for implantation
11/21/2007	CN100349613C Botulinum toxin oral formulation and use thereof for treating peptic ulcers and gastroesophageal reflux disease
11/21/2007	CN100349612C Sustained releasing microspheric preparation of glucokinase mutant and its making method
11/21/2007	CN100349611C Redfish calcitonin inhalation powder-atomizing agent and preparing method
11/21/2007	CN100349610C Oral adhering piece for treating oral exulceratio, and its prepn. method
11/21/2007	CN100349609C Cirrhosis treating medicine
11/21/2007	CN100349556C Use of autologous dermal fibroblasts for repair of skin and soft tissue defects
11/21/2007	CN100349524C Combined use of triglycerides containing medium chain fatty acids and exogenous lipolytic enzymes as feed supplements
11/20/2007	US7297836 Using variations in calcium-responsive gene products to diagnose neurodegenerative disorders; screening drugs for treating cognitive impairment
11/20/2007	US7297794 Phenoxy amine compounds and compositions for delivering active agents
11/20/2007	US7297784 Genetic enhancers comprising amino acid sequences derived from retrovirus envelope proteins coupled to core peptides, used as drugs having improve half life
11/20/2007	US7297777 Process of purification of hCG and recombinant hCG purified by that method
11/20/2007	US7297775 Polypeptide variants
11/20/2007	US7297774 Isolated or purified mutated human fibroblast growth factor receptor-4 (FGFR-4) comprising point mutation resulting in replacement of glycine with arginine; tyrosine kinase inhibitors; anticarcinogenic agents
11/20/2007	US7297771 Polypeptides having opioid receptor activity
11/20/2007	US7297768 PRO3574 polypeptide
11/20/2007	US7297766 PRO5337 polypeptides
11/20/2007	US7297765 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2007	US7297763 Mixture of IGF-1 and N,N-bis(3-D-gluconamidopropyl)-deoxycholamine that binds specifically to IGF-1 and blocks binding of IGFBP-1 and IGFBP-3; used as a standard for identifying IGF-1 indirect agonists
11/20/2007	US7297761 Pharmaceutical compositions containing exendins
11/20/2007	US7297760 Cancer associated protein
11/20/2007	US7297701 Anti-cancer cyclopenta [G]quinazoline compounds
11/20/2007	US7297685 Use of pro-apoptotic factors in treatment of atherosclerosis
11/20/2007	US7297684 breast and prostatic tumors; administration of an antisense oligodeoxynucleotide which is complementary to a portion of the gene encoding insulin-like growth factor binding protein -5
11/20/2007	US7297681 For use in therapy of growth metabolic disorders
11/20/2007	US7297680 Mixture comprising sialinated erythropoietin (EPO) for use in generating stable, human, recombinant proteins that are modified post-translationally
11/20/2007	US7297679 Eye-drops suitable for the treatment of diseases of the eye and surrounding areas; cyclosporin A, almond oil, and Polyoxyethylene
11/20/2007	US7297678 Use of repeat sequence protein polymers in personal care compositions
11/20/2007	US7297676 Thymosin alpha 1 peptide/polymer conjugates
11/20/2007	US7297551 Administering recombinant Factor C to treat gramnegative bacterial infections and to produce bacteriostasis
11/20/2007	US7297526 Human DNase
11/20/2007	US7297524 Polynucleotides for production of farnesyl dibenzodiazepinones
11/20/2007	US7297523 Human elongase genes and uses thereof
11/20/2007	US7297511 Interferon alpha: remodeling and glycoconjugation of interferon alpha
11/20/2007	US7297488 Identifying and testing antisense oligonucleotides that inhibit telomerase reverse transcriptase
11/20/2007	US7297342 Orthopaedic materials derived from keratin
11/20/2007	US7297337 Ephrin-A2 lymphocyte receptor modulator for use in treatment and prevention of renal cell carcinoma; mimetics and antitumor agents
11/20/2007	US7297334 Anti-vegf antibodies
11/20/2007	US7297332 Protease, a gene therefor and the use thereof
11/20/2007	US7297329 Mammalian common lymphoid progenitor cell
11/20/2007	US7297099 Use of osteopontin for the treatment and/or prevention of neurologic diseases
11/20/2007	CA2341410C Hydrogel compositions for the controlled release administration of growth factors
11/20/2007	CA2262409C Modified tie-2-receptor ligands
11/20/2007	CA2234615C Sustained release particles
11/20/2007	CA2229544C Cyclic peptide analogs of somatostatin
11/20/2007	CA2186126C Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii or factor ix
11/20/2007	CA2171743C Nucleotide analogs
11/20/2007	CA1341561C Manufacture and expression of large structural genes
11/17/2007	CA2587319A1 Cmklr regulation of adipogenesis and adipocyte metabolic function
11/15/2007	WO2007131218A2 Compositions and methods for modulating the immune system
11/15/2007	WO2007130886A2 Nutritional supplement and use thereof
11/15/2007	WO2007130743A2 Capreomycin derivatives and their use as antibacterials
11/15/2007	WO2007130714A1 Novel statin pharmaceutical compositions and related methods of treatment
11/15/2007	WO2007130672A2 Urodilatin cancer treatment
11/15/2007	WO2007130627A2 Il-33 in the treatment and diagnosis of diseases and disorders
11/15/2007	WO2007130575A2 Protection against oxidative damage in cells
11/15/2007	WO2007130501A2 Combination therapy for treatment of cancer
11/15/2007	WO2007130403A2 REGULATION OF ApoB BY Hspl 10 PROTEINS AND RELATED COMPOSITIONS AND METHODS
11/15/2007	WO2007130364A2 Compositions, methods, and kits for treating dry eye
11/15/2007	WO2007130302A2 Rage fusion proteins, formulations, and methods of use thereof
11/15/2007	WO2007130113A2 Parathyroid hormone analogues and methods of use
11/15/2007	WO2007130031A1 Methods for the treatment of muscular dystrophy associated with dysferlin-deficiency
11/15/2007	WO2007129999A2 Antiproliferative peptides and antibodies for their detection
11/15/2007	WO2007129952A1 Novel peptide derivatives useful as antimicrobial agents for treating wounds
11/15/2007	WO2007129674A1 Fermented product composition, cosmetic composition and method of producing the same
11/15/2007	WO2007129270A2 Cosmetic compositions comprising at least one peptide with at least one immobilized aromatic cycle
11/15/2007	WO2007129149A1 Use of cyclosporin a or melle4-cyclosporin for the treatment of acute myocardial infarction
11/15/2007	WO2007129093A2 Hla peptide therapy
11/15/2007	WO2007129077A2 Imaging agent
11/15/2007	WO2007128901A1 Use of alpha-lactalbumin for regulation of glycemia
11/15/2007	WO2007128896A2 Protease inhibitor compound, notably papain, cathepsin k and cathepsin b, and a procedure for the purification of protease inhibitor molecules
11/15/2007	WO2007128884A1 Novel genes and markers in type 2 diabetes and obesity
11/15/2007	WO2007128817A2 Insulin derivative
11/15/2007	WO2007128806A2 Methods for the in vitro screening of compounds inhibiting production of infectious hiv-1 virions
11/15/2007	WO2007128647A1 USE OF THYMOSIN α1, ALONE OR IN COMBINATION WITH PTX3 OR GANCICLOVIR, FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTION
11/15/2007	WO2007128588A2 Glutadon
11/15/2007	WO2007128564A2 Use of a compound with rankl activity

1 ... 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 ... 3163